These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. Ikeda M; Ikeda A; Longnecker R J Virol; 2001 Jun; 75(12):5711-8. PubMed ID: 11356981 [TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Ikeda M; Ikeda A; Longan LC; Longnecker R Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340 [TBL] [Abstract][Full Text] [Related]
5. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling. Ikeda M; Longnecker R Virology; 2009 Mar; 385(1):183-91. PubMed ID: 19081591 [TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. Ingham RJ; Raaijmakers J; Lim CS; Mbamalu G; Gish G; Chen F; Matskova L; Ernberg I; Winberg G; Pawson T J Biol Chem; 2005 Oct; 280(40):34133-42. PubMed ID: 16087662 [TBL] [Abstract][Full Text] [Related]
7. Lysine-independent ubiquitination of Epstein-Barr virus LMP2A. Ikeda M; Ikeda A; Longnecker R Virology; 2002 Aug; 300(1):153-9. PubMed ID: 12202215 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. Caldwell RG; Brown RC; Longnecker R J Virol; 2000 Feb; 74(3):1101-13. PubMed ID: 10627520 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Ikeda M; Longnecker R Virology; 2007 Apr; 360(2):461-8. PubMed ID: 17150237 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3. Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904 [TBL] [Abstract][Full Text] [Related]
11. Allosteric auto-inhibition and activation of the Nedd4 family E3 ligase Itch. Zhu K; Shan Z; Chen X; Cai Y; Cui L; Yao W; Wang Z; Shi P; Tian C; Lou J; Xie Y; Wen W EMBO Rep; 2017 Sep; 18(9):1618-1630. PubMed ID: 28747490 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Caldwell RG; Wilson JB; Anderson SJ; Longnecker R Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760 [TBL] [Abstract][Full Text] [Related]
13. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction. Swart R; Fruehling S; Longnecker R Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120 [TBL] [Abstract][Full Text] [Related]
14. Identification of the WW domain-interaction sites in the unstructured N-terminal domain of EBV LMP 2A. Seo MD; Park SJ; Kim HJ; Lee BJ FEBS Lett; 2007 Jan; 581(1):65-70. PubMed ID: 17174309 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the glutamate transporter EAAT1 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid-inducible kinase isoforms SGK1/3 and protein kinase B. Boehmer C; Henke G; Schniepp R; Palmada M; Rothstein JD; Bröer S; Lang F J Neurochem; 2003 Sep; 86(5):1181-8. PubMed ID: 12911626 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn. Rovedo M; Longnecker R J Virol; 2008 Sep; 82(17):8520-8. PubMed ID: 18579586 [TBL] [Abstract][Full Text] [Related]
17. The Nedd4-like family of E3 ubiquitin ligases and cancer. Chen C; Matesic LE Cancer Metastasis Rev; 2007 Dec; 26(3-4):587-604. PubMed ID: 17726579 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation. Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease. Cooper L; Longnecker R Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]